Team:RAMNOTIREN CALGARY/References

From 2014hs.igem.org

(Difference between revisions)

Latest revision as of 03:59, 21 June 2014

1
2
3
4

References

A New Strategy in the War on Cancer. (2009, October 1). . Retrieved , from http://www.ted.com/talks/david_agus_a_new_strategy_in_the_war_on_cancer.html
Targeted Cancer Therepy. (n.d.). . Retrieved , from http://www.cancer.org/acs/groups/cid/documents/webcontent/003024-pdf.pdf
http://new.ted.com/playlists/63/a_cure_for_cancer
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC205287/
http://biotech.szbk.u-szeged.hu/RG_Jegyzet/pBADg3_man.pdf
http://www.wisegeek.com/what-is-endostatin.htm

Papers:

Hooke, A., Oeschger, M. P., Zeligs, B., & Bellanti, J. Ideal Target Organism for Quantitative Bactericidal Assays. Infection and Immunity.
Anti-angiogenesis mediated by angiostatin K1–3, K1–4 and K1–4.5; Anti Angiogenesis mediated by angiostatin.
Endothelium and Vascular Development
Nussenbaum, F., & Herman, I. N. Tumor Angiogenesis . Insights and Innovations, 2010.
Antiangiogenic peptides and proteins; https://d2l.cbe.ab.ca/d2l/le/content/306178/viewContent/3812058/View Recombinant Human Angiostatin by Twice-Daily Subcutaneous Injection in Advanced Cancer

@@ Line 263: / Line 263: @@
 					<ul>
 						<li><a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/Members">Members</a></li>
-						<li><a href="https://igem.org/Team.cgi" target="_blank">Official Profile</a></li>
+						<li><a href="https://igem.org/Team.cgi?id=1295" target="_blank">Official Profile</a></li>
 						<li><a href="https://2014hs.igem.org/Team:RAMNOTIREN_CALGARY/AboutCMHS">About CMHS</a></li>
 					</ul>
@@ Line 288: / Line 288: @@
 		</div>
 	</header>
-   </h2>
-    <p>Pellentesque habitant morbi tristique senectus et netus et
+<div id="reference">
-    malesuada fames ac turpis egestas. Vestibulum tortor quam,
+<h3>References</h3><br>
-    feugiat vitae, ultricies eget, tempor sit amet, ante. Donec eu
-    libero sit amet quam egestas semper. Aenean ultricies mi vitae
+A New Strategy in the War on Cancer. (2009, October 1). . Retrieved , from http://www.ted.com/talks/david_agus_a_new_strategy_in_the_war_on_cancer.html<br>
-    est. Mauris placerat eleifend leo. Quisque sit amet est et sapien
+Targeted Cancer Therepy. (n.d.). . Retrieved , from
-    ullamcorper pharetra. Vestibulum erat wisi, condimentum sed,
+http://www.cancer.org/acs/groups/cid/documents/webcontent/003024-pdf.pdf<br>
-    commodo vitae, ornare sit amet, wisi. Aenean fermentum, elit eget
+http://new.ted.com/playlists/63/a_cure_for_cancer<br>
-    tincidunt condimentum, eros ipsum rutrum orci, sagittis tempus
+http://www.ncbi.nlm.nih.gov/pmc/articles/PMC205287/ <br>
-    lacus enim ac dui. Donec non enim in turpis pulvinar facilisis.
+http://biotech.szbk.u-szeged.hu/RG_Jegyzet/pBADg3_man.pdf <br>
-    Ut felis. Praesent dapibus, neque id cursus faucibus, tortor
+http://www.wisegeek.com/what-is-endostatin.htm <br>
-    neque egestas augue, eu vulputate magna eros eu erat. Aliquam
-    erat volutpat. Nam dui mi, tincidunt quis, accumsan porttitor,
+<h3>Papers:</h3>
-    facilisis luctus, metus.</p>
+Hooke, A., Oeschger, M. P., Zeligs, B., & Bellanti, J. Ideal Target Organism for Quantitative Bactericidal Assays. Infection and Immunity.<br>
+Anti-angiogenesis mediated by angiostatin K1–3, K1–4 and K1–4.5; Anti Angiogenesis mediated by angiostatin.<br> Endothelium and Vascular Development<br>
+Nussenbaum, F., & Herman, I. N. Tumor Angiogenesis . Insights and Innovations, 2010.<br>
+Antiangiogenic peptides and proteins; https://d2l.cbe.ab.ca/d2l/le/content/306178/viewContent/3812058/View
+Recombinant Human Angiostatin by Twice-Daily Subcutaneous Injection in Advanced Cancer<br>
 </body>
 </html>